Nucleotide and phylogenetic analysis of human papillomavirus types 6 and 11 isolated from recurrent respiratory papillomatosis in Brazil

Infection, Genetics and Evolution

Volumn 16, Issue , 2013, Pages 282-289

  de Matos, Renata Prandini Adum ^a   Sichero, Laura ^b   Mansur, Isabela Mazuco ^a   do Bonfim, Caroline Measso ^a   Bittar, Cíntia ^a   Nogueira, Rodrigo Lacerda ^b   Küpper, Daniel Salgado ^b   Valera, Fabiana Cardoso Pereira ^b   Nogueira, Maurício Lacerda ^c   Villa, Luisa Lina ^b,d   Calmon, Marilia Freitas ^a   Rahal, Paula ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FACULDADE DE MEDICINA DE SÃO JOSÉ DO RIO PRETO   (Brazil)

^d HPV Institute   (Brazil)

Author keywords

HPV variants; HPV 11; HPV 6; Phylogenetic analysis; Recurrent respiratory papillomatosis

Indexed keywords

PROTEIN E6;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BRAZIL; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; DISEASE SEVERITY; E6 EARLY GENE; FEMALE; GENETIC VARIABILITY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 6; LARYNX PAPILLOMATOSIS; LUNG TUMOR; MALE; MOLECULAR CLONING; NONHUMAN; NUCLEIC ACID ANALYSIS; NUCLEOTIDE SEQUENCE; PAPILLOMATOSIS; PHYLOGENETIC TREE; PHYLOGENY; POINT MUTATION; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEQUENCE ANALYSIS; TUMOR RECURRENCE; UTERINE CERVIX CANCER; VIRUS ISOLATION;

ADOLESCENT; ADULT; BRAZIL; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMAN PAPILLOMAVIRUS 11; HUMAN PAPILLOMAVIRUS 6; HUMANS; MALE; MIDDLE AGED; MUTATION; PAPILLOMAVIRUS INFECTIONS; PHYLOGENY; RESPIRATORY TRACT INFECTIONS; VIRAL PROTEINS;

EID: 84877817788     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2012.12.033     Document Type: Article

References (55)

1. Aragones L., Guix S., Ribes E., Bosch A., Pinto R.M. Fine-tuning translation kinetics selection as the driving force of codon usage bias in the hepatitis A virus capsid. PLoS Pathogens 2010, 6:e1000797.
2. Bernard H.U. Gene expression of genital human papillomaviruses and considerations on potential antiviral approaches. Antiviral Therapy 2002, 7:219-237.
3. Bernard H.U., Chan S.Y., Manos M.M., Ong C.K., Villa L.L., Delius H., Peyton C.L., Bauer H.M., Wheeler C.M. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. The Journal of Infectious Diseases 1994, 170:1077-1085.
4. Bernard H.U., Calleja-Macias I.E., Dunn S.T. Genome variation of human papillomavirus types: phylogenetic and medical implications. International Journal of Cancer. Journal International du Cancer 2006, 118:1071-1076.
5. Burk R.D., Chen Z., Harari A., Smith B.C., Kocjan B.J., Maver P.J., Poljak M. Classification and nomenclature system for human Alphapapillomavirus variants: general features, nucleotide landmarks and assignment of HPV6 and HPV11 isolates to variant lineages. Acta dermatovenerologica Alpina, Panonica, et Adriatica 2011, 20:113-123.
6. Chow L.T., Broker T.R., Steinberg B.M. The natural history of human papillomavirus infections of the mucosal epithelia. APMIS: acta pathologica, microbiologica, et immunologica Scandinavica 2010, 118:422-449.
7. Cid-Arregui A., Juarez V., zur Hausen H. A synthetic E7 gene of human papillomavirus type 16 that yields enhanced expression of the protein in mammalian cells and is useful for DNA immunization studies. Journal of Virology 2003, 77:4928-4937.
8. Combrinck C.E., Seedat R.Y., Randall C., Roodt Y., Burt F.J. Novel HPV-6 variants of human papillomavirus causing recurrent respiratory papillomatosis in Southern Africa. Epidemiology and Infection 2011, 140:1-7.
9. Dartmann K., Schwarz E., Gissmann L., zur Hausen H. The nucleotide sequence and genome organization of human papilloma virus type 11. Virology 1986, 151:124-130.
10. de Villiers E.M., Gissmann L., zur Hausen H. Molecular cloning of viral DNA from human genital warts. Journal of Virology 1981, 40:932-935.
11. de Villiers E.M., Gunst K., Stein H., Scherubl H. Esophageal squamous cell cancer in patients with head and neck cancer: prevalence of human papillomavirus DNA sequences. International Journal of Cancer. Journal International du Cancer 2004, 109:253-258.
12. Derkay C.S., Malis D.J., Zalzal G., Wiatrak B.J., Kashima H.K., Coltrera M.D. A staging system for assessing severity of disease and response to therapy in recurrent respiratory papillomatosis. The Laryngoscope 1998, 108:935-937.
13. Disbrow G.L., Sunitha I., Baker C.C., Hanover J., Schlegel R. Codon optimization of the HPV-16 E5 gene enhances protein expression. Virology 2003, 311:105-114.
14. Donne A.J., Hampson L., Homer J.J., Hampson I.N. The role of HPV type in recurrent respiratory papillomatosis. International Journal of Pediatric Otorhinolaryngology 2010, 74:7-14.
15. Du J., Nordfors C., Nasman A., Sobkowiak M., Romanitan M., Dalianis T., Ramqvist T. Human papillomavirus (HPV) 16 E6 variants in tonsillar cancer in comparison to those in cervical cancer in Stockholm, Sweden. PLoS One 2012, 7:e36239.
16. Gallagher T.Q., Derkay C.S. Recurrent respiratory papillomatosis: update 2008. Current Opinion in Otolaryngology & Head and Neck Surgery 2008, 16:536-542.
17. Gissmann L., zur Hausen H. Partial characterization of viral DNA from human genital warts (Condylomata acuminata). International Journal of Cancer. Journal International du Cancer 1980, 25:605-609.
18. Gissmann L., Diehl V., Schultz-Coulon H.J., zur Hausen H. Molecular cloning and characterization of human papilloma virus DNA derived from a laryngeal papilloma. Journal of Virology 1982, 44:393-400.
19. Gravitt P.E., Peyton C.L., Alessi T.Q., Wheeler C.M., Coutlee F., Hildesheim A., Schiffman M.H., Scott D.R., Apple R.J. Improved amplification of genital human papillomaviruses. Journal of Clinical Microbiology 2000, 38:357-361.
20. Gu W., Li M., Zhao W.M., Fang N.X., Bu S., Frazer I.H., Zhao K.N. TRNASer(CGA) differentially regulates expression of wild-type and codon-modified papillomavirus L1 genes. Nucleic Acids Research 2004, 32:4448-4461.
21. Guindon S., Gascuel O. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Systematic Biology 2003, 52:696-704.
22. Guindon S., Dufayard J.F., Lefort V., Anisimova M., Hordijk W., Gascuel O. New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Systematic Biology 2010, 59:307-321.
23. Halbert C.L., Demers G.W., Galloway D.A. The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells. Journal of Virology 1991, 65:473-478.
24. Hall T.A. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symposium Series 1999, 41:95-98.
25. Heinzel P.A., Chan S.Y., Ho L., O'Connor M., Balaram P., Campo M.S., Fujinaga K., Kiviat N., Kuypers J., Pfister H., et al. Variation of human papillomavirus type 6 (HPV-6) and HPV-11 genomes sampled throughout the world. Journal of Clinical Microbiology 1995, 33:1746-1754.
26. Ho L., Chan S.Y., Burk R.D., Das B.C., Fujinaga K., Icenogle J.P., Kahn T., Kiviat N., Lancaster W., Mavromara-Nazos P., et al. The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. Journal of Virology 1993, 67:6413-6423.
27. IARC Human papillomaviruses. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans/World Health Organization, International Agency for Research on Cancer 2007, 90:1-636.
28. Klozar J., Tachezy R., Rotnaglova E., Koslabova E., Salakova M., Hamsikova E. Human papillomavirus in head and neck tumors: epidemiological, molecular and clinical aspects. Wien Med Wochenschr 2010, 160:305-309.
29. Kocjan B.J., Poljak M., Cimerman M., Gale N., Potocnik M., Bogovac Z., Seme K. Prevaccination genomic diversity of human papillomavirus genotype 6 (HPV 6). Virology 2009, 391:274-283.
30. Kovelman R., Bilter G.K., Roman A., Brown D.R., Barbosa M.S. Human papillomavirus type 6: classification of clinical isolates and functional analysis of E2 proteins. The Journal of General Virology 1999, 80(Pt 9):2445-2451.
31. Longworth M.S., Laimins L.A. Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiology and Molecular Biology Reviews: MMBR 2004, 68:362-372.
32. Maver P.J., Kocjan B.J., Seme K., Potocnik M., Gale N., Poljak M. Prevaccination genomic diversity of human papillomavirus genotype 11: a study on 63 clinical isolates and 10 full-length genome sequences. Journal of Medical Virology 2011, 83:461-470.
33. McMurray H.R., Nguyen D., Westbrook T.F., McAnce D.J. Biology of human papillomaviruses. International Journal of Experimental Pathology 2001, 82:15-33.
34. Mossadegh N., Gissmann L., Muller M., Zentgraf H., Alonso A., Tomakidi P. Codon optimization of the human papillomavirus 11 (HPV 11) L1 gene leads to increased gene expression and formation of virus-like particles in mammalian epithelial cells. Virology 2004, 326:57-66.
35. Mounts P., Kashima H. Association of human papillomavirus subtype and clinical course in respiratory papillomatosis. The Laryngoscope 1984, 94:28-33.
36. Nebesio C.L., Mirowski G.W., Chuang T.Y. Human papillomavirus: clinical significance and malignant potential. International Journal of Dermatology 2001, 40:373-379.
37. Ong C.K., Chan S.Y., Campo M.S., Fujinaga K., Mavromara-Nazos P., Labropoulou V., Pfister H., Tay S.K., ter Meulen J., Villa L.L., et al. Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. Journal of Virology 1993, 67:6424-6431.
38. Posada D., Crandall K.A. MODELTEST: testing the model of DNA substitution. Bioinformatics 1998, 14:817-818.
39. Richard C., Lanner C., Naryzhny S.N., Sherman L., Lee H., Lambert P.F., Zehbe I. The immortalizing and transforming ability of two common human papillomavirus 16 E6 variants with different prevalences in cervical cancer. Oncogene 2010, 29:3435-3445.
40. Rost B., Yachdav G., Liu J. The Predict Protein Server. Nucleic Acids Research 2004, 32:W321-326.
41. Shang Q., Wang Y., Fang Y., Wei L., Chen S., Sun Y., Li B., Zhang F., Gu H. Human papillomavirus type 16 variant analysis of E6, E7, and L1 [corrected] genes and long control region in [corrected] cervical carcinomas in patients in northeast China. Journal of Clinical Microbiology 2011, 49:2656-2663.
42. Sichero L., Ferreira S., Trottier H., Duarte-Franco E., Ferenczy A., Franco E.L., Villa L.L. High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18. International Journal of Cancer. Journal International du Cancer 2007, 120:1763-1768.
43. Sichero L., Simao Sobrinho J., Lina Villa L. Oncogenic potential diverge among human papillomavirus type 16 natural variants. Virology 2012, 432:127-132.
44. Swofford D.L. Phylogenetic Analysis Using Parsimony (*and Other Methods) Version 4 2002, Sinauer Associates, Sunderland, Massachusetts.
45. Thomas J.T., Hubert W.G., Ruesch M.N., Laimins L.A. Human papillomavirus type 31 oncoproteins E6 and E7 are required for the maintenance of episomes during the viral life cycle in normal human keratinocytes. Proceedings of the National Academy of Sciences of the United States of America 1999, 96:8449-8454.
46. Thompson J.D., Gibson T.J., Plewniak F., Jeanmougin F., Higgins D.G. The CLUSTAL_X windows interface. flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Research 1997, 25:4876-4882.
47. Tyring S.K. Human papillomavirus infections: epidemiology, pathogenesis, and host immune response. Journal of the American Academy of Dermatology 2000, 43:S18-26.
48. Uversky V.N., Roman A., Oldfield C.J., Dunker A.K. Protein intrinsic disorder and human papillomaviruses: increased amount of disorder in E6 and E7 oncoproteins from high risk HPVs. Journal of Proteome Research 2006, 5:1829-1842.
49. Villa L.L., Schlegel R. Differences in transformation activity between HPV-18 and HPV-16 map to the viral LCR-E6-E7 region. Virology 1991, 181:374-377.
50. Vrtacnik Bokal E., Kocjan B.J., Poljak M., Bogovac Z., Jancar N. Genomic variants of human papillomavirus genotypes 16, 18, and 33 in women with cervical cancer in Slovenia. The Journal of Obstetrics and Gynaecology Research 2010, 36:1204-1213.
51. Wada K., Aota S., Tsuchiya R., Ishibashi F., Gojobori T., Ikemura T. Codon usage tabulated from the GenBank genetic sequence data. Nucleic Acids Research 1990, 18(Suppl):2367-2411.
52. Wiatrak B.J., Wiatrak D.W., Broker T.R., Lewis L. Recurrent respiratory papillomatosis: a longitudinal study comparing severity associated with human papilloma viral types 6 and 11 and other risk factors in a large pediatric population. The Laryngoscope 2004, 114:1-23.
53. Zhao K.N., Chen J. Codon usage roles in human papillomavirus. Reviews in Medical Virology 2011, 21:397-411.
54. Zhao K.N., Liu W.J., Frazer I.H. Codon usage bias and A+T content variation in human papillomavirus genomes. Virus Research 2003, 98:95-104.
55. Zhou J., Liu W.J., Peng S.W., Sun X.Y., Frazer I. Papillomavirus capsid protein expression level depends on the match between codon usage and tRNA availability. Journal of Virology 1999, 73:4972-4982.